Literature DB >> 22407011

Natalizumab-associated complication? First case of peripheral T cell lymphoma.

Jeffrey Schowinsky, John Corboy, Timothy Vollmer, B K Kleinschmidt-DeMasters.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407011     DOI: 10.1007/s00401-012-0967-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  7 in total

Review 1.  Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-02-04       Impact factor: 3.869

2.  Upper Gastrointestinal Tract Lymphoma With Natalizumab: Evidence of Impaired Immune Surveillance?

Authors:  Lauren Gomes; Emily Watson; Matthew Robert Smith; Edward Morris; Mike Boggild
Journal:  Neurol Clin Pract       Date:  2021-08

Review 3.  Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?

Authors:  Joachim Havla; Ingo Kleiter; Tania Kümpfel
Journal:  Ther Clin Risk Manag       Date:  2013-10-03       Impact factor: 2.423

Review 4.  Current therapeutic strategies for inflammation following traumatic spinal cord injury.

Authors:  Priyanka L Singh; Nitin Agarwal; James C Barrese; Robert F Heary
Journal:  Neural Regen Res       Date:  2012-08-15       Impact factor: 5.135

5.  Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.

Authors:  Jennie Y Law; Dong W Kim; Ariel Sturgis; Harris V Naina
Journal:  Clin Med Insights Oncol       Date:  2015-07-01

Review 6.  Safety of Newer Disease Modifying Therapies in Multiple Sclerosis.

Authors:  Georges Jalkh; Rachelle Abi Nahed; Gabrielle Macaron; Mary Rensel
Journal:  Vaccines (Basel)       Date:  2020-12-26

Review 7.  Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.

Authors:  Raquel Planas; Roland Martin; Mireia Sospedra
Journal:  Patient Relat Outcome Meas       Date:  2014-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.